Healius Limited (HLS.AX)
AUD 1.4
(-1.75%)
AUD 1.4
(-1.75%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 420.8 Million AUD | -25.14% |
| 2023 | 562.1 Million AUD | -7.26% |
| 2022 | 606.1 Million AUD | 134.83% |
| 2021 | 258.1 Million AUD | -68.14% |
| 2020 | 810.1 Million AUD | -0.27% |
| 2019 | 812.3 Million AUD | -5.73% |
| 2018 | 861.7 Million AUD | -2.01% |
| 2017 | 879.4 Million AUD | -1.97% |
| 2016 | 897.1 Million AUD | -15.15% |
| 2015 | 1.05 Billion AUD | -3.88% |
| 2014 | 1.09 Billion AUD | 2.16% |
| 2013 | 1.07 Billion AUD | 0.45% |
| 2012 | 1.07 Billion AUD | -3.77% |
| 2011 | 1.11 Billion AUD | 11.31% |
| 2010 | 1 Billion AUD | 43144.3% |
| 2009 | 2.31 Million AUD | -30.11% |
| 2008 | 3.31 Million AUD | -97.91% |
| 2007 | 158.62 Million AUD | 40.01% |
| 2006 | 113.29 Million AUD | 39.54% |
| 2005 | 81.18 Million AUD | 12.76% |
| 2004 | 72 Million AUD | 5.88% |
| 2003 | 68 Million AUD | -13.38% |
| 2002 | 78.5 Million AUD | 21.52% |
| 2001 | 64.6 Million AUD | 146.66% |
| 2000 | 26.19 Million AUD | 64.32% |
| 1999 | 15.93 Million AUD | 51.07% |
| 1998 | 10.55 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 FY | 420.8 Million AUD | -25.14% |
| 2024 Q2 | 412.7 Million AUD | 0.0% |
| 2024 Q4 | 420.8 Million AUD | 0.0% |
| 2023 Q2 | 631.5 Million AUD | 0.0% |
| 2023 Q4 | 562.1 Million AUD | 0.0% |
| 2023 FY | 562.1 Million AUD | -7.26% |
| 2022 Q4 | 606.1 Million AUD | 0.0% |
| 2022 FY | 606.1 Million AUD | 134.83% |
| 2022 Q2 | 329.8 Million AUD | 0.0% |
| 2021 Q2 | 217.3 Million AUD | 0.0% |
| 2021 FY | 258.1 Million AUD | -68.14% |
| 2021 Q4 | 258.1 Million AUD | 0.0% |
| 2020 Q4 | 810.1 Million AUD | 0.0% |
| 2020 FY | 810.1 Million AUD | -0.27% |
| 2020 Q2 | 867.4 Million AUD | 0.0% |
| 2019 Q4 | 812.3 Million AUD | 0.0% |
| 2019 Q2 | 763.3 Million AUD | 0.0% |
| 2019 FY | 812.3 Million AUD | -5.73% |
| 2018 Q4 | 861.7 Million AUD | 0.0% |
| 2018 Q2 | 878.4 Million AUD | 0.0% |
| 2018 FY | 861.7 Million AUD | -2.01% |
| 2017 Q4 | 879.4 Million AUD | 0.0% |
| 2017 FY | 879.4 Million AUD | -1.97% |
| 2017 Q2 | 917.9 Million AUD | 0.0% |
| 2016 Q4 | 897.1 Million AUD | 0.0% |
| 2016 FY | 897.1 Million AUD | -15.15% |
| 2016 Q2 | 1.16 Billion AUD | 0.0% |
| 2015 Q4 | 1.05 Billion AUD | 0.0% |
| 2015 FY | 1.05 Billion AUD | -3.88% |
| 2015 Q2 | 1.02 Billion AUD | 0.0% |
| 2014 Q2 | 1.09 Billion AUD | 0.0% |
| 2014 FY | 1.09 Billion AUD | 2.16% |
| 2014 Q4 | 1.09 Billion AUD | 0.0% |
| 2013 FY | 1.07 Billion AUD | 0.45% |
| 2013 Q4 | 1.07 Billion AUD | 0.0% |
| 2013 Q2 | 1.07 Billion AUD | 0.0% |
| 2012 Q4 | 1.07 Billion AUD | 0.0% |
| 2012 FY | 1.07 Billion AUD | -3.77% |
| 2011 FY | 1.11 Billion AUD | 11.31% |
| 2011 Q4 | 1.11 Billion AUD | 0.0% |
| 2010 Q4 | 1 Billion AUD | 0.0% |
| 2010 FY | 1 Billion AUD | 43144.3% |
| 2009 FY | 2.31 Million AUD | -30.11% |
| 2009 Q4 | 2.31 Million AUD | 0.0% |
| 2008 Q4 | 3.31 Million AUD | 0.0% |
| 2008 FY | 3.31 Million AUD | -97.91% |
| 2007 FY | 158.62 Million AUD | 40.01% |
| 2007 Q4 | 158.62 Million AUD | 0.0% |
| 2006 Q4 | 113.29 Million AUD | 0.0% |
| 2006 FY | 113.29 Million AUD | 39.54% |
| 2005 Q4 | 81.18 Million AUD | 0.0% |
| 2005 FY | 81.18 Million AUD | 12.76% |
| 2004 Q4 | 88.89 Million AUD | 0.0% |
| 2004 FY | 72 Million AUD | 5.88% |
| 2003 FY | 68 Million AUD | -13.38% |
| 2003 Q4 | 88.63 Million AUD | 0.0% |
| 2002 Q4 | 90.8 Million AUD | 0.0% |
| 2002 FY | 78.5 Million AUD | 21.52% |
| 2001 FY | 64.6 Million AUD | 146.66% |
| 2001 Q4 | 75.65 Million AUD | 0.0% |
| 2000 Q4 | 31.69 Million AUD | 0.0% |
| 2000 FY | 26.19 Million AUD | 64.32% |
| 1999 Q4 | 19.57 Million AUD | 0.0% |
| 1999 FY | 15.93 Million AUD | 51.07% |
| 1998 FY | 10.55 Million AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Australian Clinical Labs Limited | 55.06 Million AUD | -664.202% |
| BCAL Diagnostics Limited | 400.22 Thousand AUD | -105041.909% |
| Genetic Signatures Limited | - AUD | -Infinity% |
| Genetic Technologies Limited | - AUD | -Infinity% |
| Imagion Biosystems Limited | 750 Thousand AUD | -56006.667% |
| Integral Diagnostics Limited | 219.75 Million AUD | -91.485% |
| INOVIQ Ltd | - AUD | -Infinity% |
| Microba Life Sciences Limited | - AUD | -Infinity% |
| Monash IVF Group Limited | 59.56 Million AUD | -606.455% |
| Rhythm Biosciences Limited | - AUD | -Infinity% |
| Sonic Healthcare Limited | 2.69 Billion AUD | 84.359% |